Perinatal depression and anxiety remain underdiagnosed and undertreated despite ACOG guidelines recommending universal, repeated screening across pregnancy and postpartum visits.
Behavioral activation significantly reduced suicidal ideation in women with perinatal depression, showing effectiveness whether delivered in-person or remotely by specialists and non-specialists.
This study uncovers how trauma, isolation, loss of identity, and lack of support can overlap and amplify each other, deepening despair and driving suicide risk among women in the perinatal period.
This study provides valuable insight into the inequities in perinatal mental healthcare and suggests that the most significant barriers to mental healthcare may occur at the provider referral level.
This large cohort study from Taiwan indicates that the concomitant use of antidepressants and benzodiazepines during the first trimester is not associated with a substantial increase in risk for overall malformations.
May 1, 2024 is World Maternal Mental Health Day, coming together to increase awareness of perinatal mood and anxiety disorders.
The largest GWAS study to date provides evidence that despite a high correlation with MDD, PPD may have unique genetic components.
Machine learning can be used to analyze data contained within the electronic health record to accurately predict which individuals are at increased risk for postpartum depression.
A wide range of delivery options may be effective for addressing symptoms of depression in perinatal individuals, and could therefore be leveraged to expand access to treatments.
Compared to individuals with histories of psychiatric illness prior to pregnancy, perinatal individuals without a prepregnancy psychiatric history were less likely to be screened, referred, and treated for depression.
